2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Dimerix Bioscience Pty Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan Propagermanium, Placebo - Focal Segmental Glomerulosclerosis | Phase 2 | Completed | Dimerix Bioscience Pty Ltd | 8 | 2018-11-08 | 2022-07-29 |
| Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan Propagermanium, Placebo - Diabetic Kidney Disease | Phase 2 | Completed | Dimerix Bioscience Pty Ltd | 45 | 2018-11-06 | 2022-07-29 |
Diabetic Nephropathies (1) · Glomerulosclerosis, Focal Segmental (1)
propagermanium (2)
Australia (2)
Simon Roger, MD (2)